Invention Publication
EP2274296A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
有权
羟甲基吡咯烷作为β3肾上腺素能受体激动剂
- Patent Title: HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
- Patent Title (中): 羟甲基吡咯烷作为β3肾上腺素能受体激动剂
-
Application No.: EP09726940.1Application Date: 2009-03-23
-
Publication No.: EP2274296A1Publication Date: 2011-01-19
- Inventor: BERGER, Richard , CHANG, Lehua , EDMONDSON, Scott, D. , GOBLE, Stephen, D. , HARPER, Bart , KAR, Nam, Fung , KOPKA, Ihor, E. , LI, Bing , MORRIELLO, Gregori, J. , MOYES, Chris, R. , SHEN, Dong-ming , WANG, Liping , WENDT, Harvey , ZHU, Cheng
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: 126 East Lincoln Avenue Rahway, NJ 07065 US
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: 126 East Lincoln Avenue Rahway, NJ 07065 US
- Agency: Horgan, James Michael Frederic
- Priority: US123062P 20080404
- International Announcement: WO2009123870 20091008
- Main IPC: C07D401/06
- IPC: C07D401/06 ; C07D401/14 ; C07D405/14 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D487/04 ; C07D495/04 ; A61K31/4406 ; A61P13/10
Abstract:
The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Public/Granted literature
- EP2274296B1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS Public/Granted day:2012-10-17
Information query
